Antimalarial Drug Artemotil Shows Promise Against Cartilage Scarring in Osteoarthritis
New research shows the antimalarial derivative Artemotil suppresses STC1-driven TGF-beta/SMAD2/3 signalling to reduce fibrotic cartilage remodelling in osteoarthritis models.
